联合临床与扩散基谱成像指标预测慢性颈椎病性脊髓病减压术后结局的分析
研究纳入50例脊髓型颈椎病(CSM)患者和20例健康对照,提取扩散基谱成像(DBSI)与扩散张量成像(DTI)指标,分别及联合临床指标训练支持向量机(SVM)预测术后改良日本骨科协会(mJOA)评分变化。联合临床与DBSI指标时SVM准确率和曲线下面积分别为88.1%和0.95,优于联合临床与DTI指标的66.7%和0.65。
要点
- 联合临床与DBSI指标训练SVM预测CSM术后结局,准确率88.1%、AUC 0.95。
- 联合临床与DTI指标训练SVM,准确率66.7%、AUC 0.65。
- DBSI联合临床表现有望作为预测CSM患者结局的替代指标。
核心结论
- 联合临床与DBSI指标的SVM在预测CSM患者结局方面显示出临床应用前景。
- DBSI指标结合临床表现可能作为预测CSM患者结局的替代指标。
研究设计与样本
- 研究纳入50例CSM患者和20例健康对照,均接受扩散加权MRI检查。
- 以全部脊髓白质为感兴趣区(ROI),提取DBSI和DTI指标,取每例患者的中位数用于分析。
- 使用优化超参数的SVM分别及联合临床与影像指标训练,以术前术后mJOA评分变化判定患者结局。
主要发现
- 联合临床与DBSI指标训练SVM时性能最高:预测mJOA评分结局的准确率为88.1%,AUC为0.95。
- 联合临床与DTI指标训练SVM时准确率为66.7%,AUC为0.65。
- 每次SVM迭代均报告准确率、精确率、召回率和F1分数。
关键数值与推荐
- 以mJOA评分变化判定结局时,临床联合DBSI指标的SVM准确率88.1%、AUC 0.95。
- 以mJOA评分变化判定结局时,临床联合DTI指标的SVM准确率66.7%、AUC 0.65。
临床怎么用
- 作者认为联合临床与DBSI指标的SVM在预测CSM患者结局方面显示出临床应用前景。
- 作者认为DBSI指标结合临床表现可能作为预测CSM患者结局的替代指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Cervical spondylotic myelopathy (CSM) is the most common cause of chronic spinal cord injury, a significant public health problem. Diffusion tensor imaging (DTI) is a neuroimaging technique widely used to assess CNS tissue pathology and is increasingly used in CSM. However, DTI lacks the needed accuracy, precision, and recall to image pathologies of spinal cord injury as the disease progresses. Thus, the authors used diffusion basis spectrum imaging (DBSI) to delineate white matter injury more accurately in the setting of spinal cord compression. It was hypothesized that the profiles of multiple DBSI metrics can serve as imaging outcome predictors to accurately predict a patient's response to therapy and his or her long-term prognosis. This hypothesis was tested by using DBSI metrics as input features in a support vector machine (SVM) algorithm. METHODS: Fifty patients with CSM and 20 healthy controls were recruited to receive diffusion-weighted MRI examinations. All spinal cord white matter was identified as the region of interest (ROI). DBSI and DTI metrics were extracted from all voxels in the ROI and the median value of each patient was used in analyses. An SVM with optimized hyperparameters was trained using clinical and imaging metrics separately and collectively to predict patient outcomes. Patient outcomes were determined by calculating changes between pre- and postoperative modified Japanese Orthopaedic Association (mJOA) scale scores. RESULTS: Accuracy, precision, recall, and F1 score were reported for each SVM iteration. The highest performance was observed when a combination of clinical and DBSI metrics was used to train an SVM. When assessing patient outcomes using mJOA scale scores, the SVM trained with clinical and DBSI metrics achieved accuracy and an area under the curve of 88.1% and 0.95, compared with 66.7% and 0.65, respectively, when clinical and DTI metrics were used together. CONCLUSIONS: The accuracy and efficacy of the SVM incorporating clinical and DBSI metrics show promise for clinical applications in predicting patient outcomes. These results suggest that DBSI metrics, along with the clinical presentation, could serve as a surrogate in prognosticating outcomes of patients with CSM.
引用
- Jayasekera D, Zhang JK, Blum J, et al. Analysis of combined clinical and diffusion basis spectrum imaging metrics to predict the outcome of chronic cervical spondylotic myelopathy following cervical decompression surgery. J Neurosurg Spine. 2022. PMID: 35523255. doi:10.3171/2022.3.SPINE2294
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。